Adjuvant radiotherapy in the management of porocarcinoma with lymphatic micrometastasis

Alper Kahvecioglu, Gonca Elcin, Saadettin Kilickap, Ozay Gokoz, Gozde Yazici

Vol 19, No 2 (2023)

Case report

Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy

Joanna Terebińska, Robert Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, Arkadiusz Zegadło, Emil Lisiak, Artur Maliborski, Renata Duchnowska

Vol 19, No 2 (2023)

Clinical vignette

Challenges in the diagnosis and treatment of peritoneal mesothelioma: a case study and review of the literature

Karol Miklusiak, Agnieszka Łazarczyk, Joanna Szpor, Łukasz Chmura, Paweł M. Potocki

Vol 19, No 2 (2023)

Case report

Survival of pancreatic cancer patients treated with nab-paclitaxel (nab-P) in clinical practice: analysis of National Health Fund data

Ireneusz Raczyński, Barbara Radecka, Maciej Krzakowski

Vol 19, No 6 (2023)

Research paper

A case of pathologic complete response after neoadjuvant triplet chemotherapy for locally advanced colon cancer with mismatch repair enzyme proficiency

Mehmet Zahid Kocak, Murat Cakir, Ulku Kerimoglu, Murat Araz, Melek Karakurt Eryilmaz, Perran Fulden Yumuk, Mehmet Artac

Vol 19, No 2 (2023)

Case report

Immunotherapy for gastroesophageal cancer

Marek Gełej, Barbara Radecka, Monika Kotyla, Weronika Radecka, Tomasz Kubiatowski

Vol 19, No 3 (2023)

Review paper

Immunotherapy for colorectal cancer

Barbara Radecka, Marek Gełej, Monika Kotyla, Tomasz Kubiatowski

Vol 19, No 3 (2023)

Review paper

Circulating microRNAs as a potential diagnostic marker in chronic pancreatitis, pancreatic cancer and colorectal cancer

Agnieszka Mądro, Weronika Kazimierak, Anna Grenda, Paweł Krawczyk

Vol 19, No 1 (2023)

Research paper

Common statement of experts of the Polish Oncological Society, Polish Lung Cancer Group, Polish Society of Lung Diseases, Polish Society of Gastroenterology, Polish Society of Endocrinology, and the Polish Society of Cardiology for minimal requirements in diagnosis and monitoring of selected adverse events of immunotherapy in oncological patients

Bożena Cybulska-Stopa, Adam Antczak, Dariusz M. Kowalski, Beata Kos-Kudła, Tomasz Kubiatowski, Przemysław Leszek, Adam Maciejczyk, Jarosław Reguła, Paweł Wiechno, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Diagnosis and treatment of rhabdomyosarcomas

Michał Łomiak, Tomasz Świtaj, Mateusz Spałek, Joanna Radzikowska, Marzanna Chojnacka, Sławomir Falkowski, Michał Wągrodzki, Wojciech Kukwa, Anna Szumera-Ciećkiewicz, Piotr Rutkowski, Anna M. Czarnecka

Vol 19, No 4 (2023)

Review paper

Optimization of diagnostic and therapeutic management in patients with stage III non-small cell lung cancer — experience of the centers in Poznań

Maciej Bryl, Piotr Milecki, Mirosława Matecka-Nowak, Jolanta Lubin, Anna Rucińska, Cezary Piwkowski

Vol 19, No 3 (2023)

Review paper

Patterns of multiple primaries in fortyfour cancer patients: a single-center clinical experience

Mehmet Esat Duymus, Tolga Koseci, Mehmet Serindere, Meral Ceylan, Abdullah Bulgurcu, Ozlem Ipci, Cemile Karadeniz, Yusuf Murat Bag, Dilsa Mizrak Kaya

Vol 19, No 1 (2023)

Research paper

Factors affecting change in renal function after contrast-enhanced computed tomography in cancer patients

Aleksandra Semeniuk-Wojtaś, Arkadiusz Lubas, Aneta Gawin, Maciej Małyszko, Maksymilian Baryła, Rafał Stec, Jolanta Małyszko

Vol 19, No 1 (2023)

Research paper

On the completion of the year 2022 for Oncology in Clinical Practice

Maciej Krzakowski, Łukasz Stolarczyk

Vol 18, No 6 (2022)

Editorial

Delays in the diagnosis of lung cancer patients in Poland

Karolina P. Nalewaj, Paweł Krawczyk, Izabela Chmielewska, Janusz Milanowski

Vol 19, No 1 (2023)

Research paper

Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography over conventional imaging studies to detect malignant lesions in staging and restaging after radically treated primary and recurrent locoregional cutaneous melanoma

Zhivka Dancheva, Aneliya Klisarova, Strahil Strashilov, Vasil Nanev, Assia Konsoulova

Vol 19, No 1 (2023)

Research paper

Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients

Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Atezolizumab in the treatment of patients with breast cancer

Katarzyna Pogoda, Agnieszka Jagiełło-Gruszfeld, Michał Kunkiel, Wojciech Olszewski

Vol 19, No 4 (2023)

Review paper

Epithelioid inflammatory myofibroblastic sarcoma of the lung ALK+/ NTRK+/ PD-L1+

Gabriele Gaggero, Davide Taietti, Veronica Parrella, Camilla Gennaioli, Antonio Guadagno

Vol 19, No 2 (2023)

Clinical vignette

Niraparib maintenance in newly diagnosed advanced ovarian cancer — review and case series

Martyna Tyszka, Rafał Stec

Vol 19, No 6 (2023)

Review paper

Nivolumab in the treatment of thoracic cancer — new possibilities

Magdalena Knetki-Wróblewska, Kamila Wojas-Krawczyk

Vol 19, No 4 (2023)

Review paper

Overall survival of patients with metastatic KRAS wild type colorectal cancer patients treated with anti-EGFR third line monotherapy

Sylwia Dębska-Szmich, Magdalena Krakowska, Katarzyna Staniecka, Paulina Krzeptowska, Jakub Dębski, Maria Dzierżak, Magdalena Wąsik, Joanna Gadzinowska, Maja Habib-Lisik

Vol 18, No 6 (2022)

Research paper

Expert recommendations on diagnostic-therapeutic management of melanoma patients

Piotr Rutkowski, Piotr J. Wysocki, Katarzyna Kozak, Anna Nasierowska-Guttmejer, Arkadiusz Jeziorski, Wojciech M. Wysocki, Ewa Kalinka, Tomasz Świtaj, Grażyna Kamińska-Winciorek, Anna M. Czarnecka, Hanna Koseła-Paterczyk, Bożena Cybulska-Stopa, Piotr Wiśniewski, Anna Szumera-Ciećkiewicz, Marcin Zdzienicki, Marek Ziobro, Jacek Fijuth, Andrzej Kawecki, Andrzej Tysarowski, Bożena Romanowska-Dixon, Anna Markiewicz, Marek Dedecjus, Tomasz Kubiatowski, Kamil Dolecki, Hanna Tchórzewska-Korba, Lidia Rudnicka, Witold Owczarek, Maciej Krzakowski

Vol 18, No 6 (2022)

Guidelines / Expert consensus

Case report of radiation-induced lung injury with trastuzumab emtansine: the lung also matters

Ezgi Gurlek, Melek Tugce Yilmaz, Melis Gultekin, Sercan Aksoy, Ferah Yildiz

Vol 18, No 6 (2022)

Case report

Evaluation of survival outcomes in patients with sporadic, advanced, unresectable well-differentiated pancreatic neuroendocrine tumors treated initially with octreotide LAR and subsequent therapeutical approaches on relapse. A real-world data set

Agnieszka Kolasińska-Ćwikła, Klaudia Gutowska, Karolina Osowiecka, Tomasz Bednarczuk, Anna Słoniewska, Katarzyna Roszkowska-Purska, Jakub Pałucki, Jarosław B. Ćwikła

Vol 18, No 5 (2022)

Research paper